Study of peripheral BRAFV600E mutation as a possible novel marker for papillary thyroid carcinomas

Jin Young Kwak, Jong Ju Jeong, Sang Wook Kang, Seulkee Park, Jong Rak Choi, Seo Jin Park, Eun Kyung Kim, Woong Youn Chung

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)


Background The BRAFV600E mutation can be detected peripherally in the serum of patients with thyroid cancer. The purpose of this study was to establish the value of detecting the peripheral BRAFV600E mutation as a serum tumor marker in this population. Methods In this study, we obtained 94 serum samples from patients with papillary thyroid cancer positive for the BRAFV600E mutation in the tumor itself. The serum samples were analyzed for BRAFV600E mutation using real-time polymerase chain reaction (PCR). Results Sixty-seven patients (71.3%) had papillary thyroid microcarcinoma and 26 patients (27.7%) had underlying lymphocytic thyroiditis. Forty-three patients (45.7%) were found to have stage III or stage IV thyroid cancer. None of the patients had a detectable serum BRAFV600E mutation. Conclusion We were unable to identify peripheral BRAFV600E mutations in patients with papillary thyroid cancer using real-time PCR. Further studies will be needed to validate our results using various diagnostic methods.

Original languageEnglish
Pages (from-to)1630-1633
Number of pages4
JournalHead and Neck
Issue number11
Publication statusPublished - 2013 Nov

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology


Dive into the research topics of 'Study of peripheral BRAF<sup>V600E</sup> mutation as a possible novel marker for papillary thyroid carcinomas'. Together they form a unique fingerprint.

Cite this